| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/04/2009 | US20090142841 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 06/04/2009 | US20090142831 Placental stem cells |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/04/2009 | US20090142783 Human p51 Genes and Gene Products Thereof |
| 06/04/2009 | US20090142397 Reduction of dermal scarring |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142334 DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE |
| 06/04/2009 | US20090142329 Interleukin-1 Beta Converting Enzyme Like Apoptosis Protease-3 and 4 |
| 06/04/2009 | US20090142302 Insulin-like growth factor binding protein 7 for treatment of cancer |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | CA2707009A1 Methods for inhibiting fascin |
| 06/04/2009 | CA2706603A1 Method for producing vaccinal viral strain of a virus of the reoviridae family |
| 06/03/2009 | EP2065396A1 Interleukin-19 |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP2064235A1 The death receptor cd95 controls neurogenesis of adult neural stem cells in vivo and in vitro |
| 06/03/2009 | EP2063906A1 Methods and compositions for promoting organ development |
| 06/03/2009 | EP2063904A1 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases |
| 06/03/2009 | EP2063703A1 Method of improving renal function |
| 06/03/2009 | EP1660135B1 Method of treating hepatocellular carcinoma |
| 06/03/2009 | EP1565714A4 Uncaging devices |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | CN101448528A Il-1alpha immunization induces autoantibodies protective against atherosclerosis |
| 06/03/2009 | CN101448527A Cell-matrix microspheres, methods for preparation and applications |
| 06/03/2009 | CN101448526A Seneca valley virus based compositions and methods for treating disease |
| 06/03/2009 | CN101445802A Novel porcine circovirus virus, vaccines and diagnosis agent |
| 06/03/2009 | CN101444629A Non-injection gene therapy medicine and medicine box thereof |
| 06/03/2009 | CN101444628A Gene therapy medicine for remedying erectile dysfunction and medicine box thereof |
| 06/03/2009 | CN100494380C A nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its fragment and application |
| 06/03/2009 | CN100494213C Process for preparing synergistic factor in artificial blood, nucleotide sequence used thereby |
| 06/03/2009 | CN100493618C Series non-virus vector, and medicinal composition containing same |
| 06/03/2009 | CN100493617C Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof |
| 06/03/2009 | CN100493616C Polyepitope and composite polyepitope DNA vaccine of HIV |
| 06/02/2009 | US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
| 06/02/2009 | US7541437 Breast cancer resistance protein (BCRP) and the DNA which encode it |
| 06/02/2009 | US7541344 Modulation of survivin expression |
| 06/02/2009 | US7541343 Antiproliferative agents; administering protein; restenosis, atherosclerosis; cancer |
| 06/02/2009 | US7541193 Caged sensors, regulators and compounds and uses thereof |
| 06/02/2009 | US7541189 complex of a certain ARNT family transcription coupling factor and a certain transcription regulatory factor with ability of exerting a promotive activity on the CME sequence; Down's syndrome |
| 06/02/2009 | US7541179 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541035 Immunogenic peptides for the treatment of prostate and breast cancer |
| 06/02/2009 | US7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors |
| 06/02/2009 | CA2371728C High dose radionuclide complexes for bone marrow suppression |
| 06/02/2009 | CA2340416C Co-lyophilized complex of a nucleic acid vector and a formulating agent |
| 06/02/2009 | CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/02/2009 | CA2068863C Particle-mediated transformation of animal tissue cells |
| 05/28/2009 | WO2009066763A1 Preparation for application to body surface and preparation holding sheet for application to body surface |
| 05/28/2009 | WO2009065994A1 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence |
| 05/28/2009 | WO2009065232A1 Cancer diagnostic and therapeutic methods that target plk4/sak |
| 05/28/2009 | WO2009065226A1 Modulation of tdag51 to inhibit scar formation in skin wound healing and internal organ fibrosis |
| 05/28/2009 | WO2005017112A3 Methods of inhibiting cancer growth by binding to nuclear receptors |
| 05/28/2009 | US20090138204 Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy |
| 05/28/2009 | US20090137787 Janus family kinases and identification of immune modulators |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137505 Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same |
| 05/28/2009 | US20090137501 Resistance Genes |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/28/2009 | US20090136464 Methods and compositions for cell therapy |
| 05/28/2009 | US20090136463 Schwann Cell Bridge Implants and Phosphodiesterase Inhibitors to Stimulate CNS Nerve Regeneration |
| 05/28/2009 | US20090136462 Peptides derived from Uroplakin Ia, Ib, II and III, Prostate specific antigen, Prostate acid phosphatase and Prostate specific membrane antigen, BA-46, Mucin, and Teratocarcinoma-derived growth factor; bladder, prostate and breast cancers; antimetastasis agents |
| 05/28/2009 | US20090136453 Methods for treating pain |
| 05/28/2009 | US20090136419 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/28/2009 | CA2706467A1 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence |
| 05/28/2009 | CA2706404A1 Preparation for body surface application and preparation for body suface application-holding sheet |
| 05/28/2009 | CA2706075A1 Cancer diagnostic and therapeutic methods that target plk4/sak |
| 05/27/2009 | EP2062919A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062918A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062597A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 05/27/2009 | EP2062023A2 Intergenic sites between conserved genes in the genome of modified vaccinia ankara (mva) vaccinia virus |
| 05/27/2009 | EP2061516A2 Oligonucleotide non-viral delivery systems |
| 05/27/2009 | EP2061515A2 Long lasting drug formulations |
| 05/27/2009 | EP2061514A2 An aqueous formulation for selective targeting and delivering gene to cancer cells |
| 05/27/2009 | EP2061482A1 Method of modulation of expression of epidermal growth factor receptor (egfr) involving mirna |
| 05/27/2009 | EP2061433A2 Compositions and methods for enhancing transport through mucus |
| 05/27/2009 | EP1903874A4 Aav vectors encoding superoxide dismutase |
| 05/27/2009 | EP1581610A4 Use of chimeric nucleases to stimulate gene targeting |
| 05/27/2009 | EP1337554B1 Novel compounds |
| 05/27/2009 | EP1235915B1 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/27/2009 | EP1003850B1 Inhibitors of dna immunostimulatory sequence activity |
| 05/27/2009 | CN101443050A Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders |
| 05/27/2009 | CN101443049A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/27/2009 | CN101443048A Dendritic polymers with enhanced amplification and interior functionality |
| 05/27/2009 | CN101443047A Inhibition of Li expression in mammalian cells |
| 05/27/2009 | CN101443046A Methods and compositions for the treatment of polycystic diseases |
| 05/27/2009 | CN101440379A Obtaining method and use of novel oncolytic adenovirus construct with selective tumor blockage STAT3 |
| 05/27/2009 | CN101440378A Construction scheme and use of recombinant adeno related virus containing 16 type HPV antisense E7 gene |
| 05/27/2009 | CN101440359A Avian influenza viral vaccine and preparation thereof |
| 05/27/2009 | CN101440126A Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 05/27/2009 | CN101439189A Use of zebra fish Caspy2 gene in preparing medicament for treating tumor |
| 05/27/2009 | CN100491531C Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of non-essential gene |
| 05/27/2009 | CN100491528C Nucleic acid sequence related with risperidone clinical curative effect |
| 05/27/2009 | CN100491521C Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |